Article
Comprehensive insights on genetic alterations and immunotherapy prognosis in Chinese melanoma patients.
Scientific reports - 18 Jul 2024
Jia Dong-Dong, Li Tao
Abstract excerpt
Immune checkpoint inhibitors (ICI) have emerged as a promising therapeutic option for melanoma, which demonstrating improved clinical outcomes in melanoma patients regardless of specific genetic mutations. However, the identification of reliable biomarkers for predicting immunotherapy response and prognosis remains a challenge. In this study, we performed genetic profiling of the melanoma patients with different...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
